TabMenu

Poverty and InequalitySexual and Reproductive HealthFamily, Maternal & Child HealthMethodology

Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial

TitleDevelopment of methods for cross-sectional HIV incidence estimation in a large, community randomized trial
Publication TypeJournal Article
Year of Publication2013
AuthorsLaeyendecker, O, Kulich, M, Donnell, D, Komárek, A, Omelka, M, Mullis, CE, Szekeres, G, Piwowar-Manning, E, Fiamma, A, Gray, RH, Lutalo, T, Morrison, CS, Salata, RA, Chipato, T, Celum, C, Kahle, EM, Taha, TE, Kumwenda, NI, Karim, QA, Naranbhai, V, Lingappa, JR, Sweat, MD, Coates, T, Eshleman, SH
JournalPLoS ONE
Volume8
Paginatione78818
Accession Number24236054
KeywordsSexual and Reproductive Health
Abstract

Background: Accurate methods of HIV incidence determination are critically needed to monitor the epidemic and determine the population level impact of prevention trials. One such trial, Project Accept, a Phase III, community-randomized trial, evaluated the impact of enhanced, community-based voluntary counseling and testing on population-level HIV incidence. The primary endpoint of the trial was based on a single, cross-sectional, post-intervention HIV incidence assessment. Methods and Findings: Test performance of HIV incidence determination was evaluated for 403 multi-assay algorithms [MAAs] that included the BED capture immunoassay [BED-CEIA] alone, an avidity assay alone, and combinations of these assays at different cutoff values with and without CD4 and viral load testing on samples from seven African cohorts (5,325 samples from 3,436 individuals with known duration of HIV infection [1 month to <10 years]). The mean window period (average time individuals appear positive for a given algorithm) and performance in estimating an incidence estimate (in terms of bias and variance) of these MAAs were evaluated in three simulated epidemic scenarios (stable, emerging and waning). The power of different test methods to detect a 35% reduction in incidence in the matched communities of Project Accept was also assessed. A MAA was identified that included BED-CEIA, the avidity assay, CD4 cell count, and viral load that had a window period of 259 days, accurately estimated HIV incidence in all three epidemic settings and provided sufficient power to detect an intervention effect in Project Accept. Conclusions: In a Southern African setting, HIV incidence estimates and intervention effects can be accurately estimated from cross-sectional surveys using a MAA. The improved accuracy in cross-sectional incidence testing that a MAA provides is a powerful tool for HIV surveillance and program evaluation.

PMCID

3827276